William Reiss
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 2%
- Long-Term Effects of COVID-19
Papers in
- Rheumatology 17
- Rheumatoid Arthritis Research and Therapies 17
- Systemic Lupus Erythematosus Research 5
- Genetics 11
- Chronic Lymphocytic Leukemia Research 11
- Co-authors
- Karen S. Oles (1 shared paper)Emma Kaplan‐Lewis (1 shared paper)Jamie Freedman (1 shared paper)Rachel Baden (1 shared paper)Gerard J. Criner (1 shared paper)Carlos Salama (1 shared paper)Jian Han (1 shared paper)Linda Yau (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (9 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (3 papers)Journal of Vascular Surgery (2 papers)Rheumatology and Therapy (2 papers)The Journal of Clinical Pharmacology (2 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
William Reiss
34 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Infectious Diseases 641
- Neurology 463
- Rheumatology 199
- Critical Care and Intensive Care Medicine 66
- Pharmacology 106
Countries citing papers authored by William Reiss
This map shows the geographic impact of William Reiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Reiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Reiss more than expected).
Fields of papers citing papers by William Reiss
This network shows the impact of papers produced by William Reiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Reiss. The network helps show where William Reiss may publish in the future.
Co-authors
The 25 scholars most cited alongside William Reiss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia Hit paper breakdown → | 2020 | 798 |
| 2 | 1996 | 131 | |
| 3 | 2016 | 82 | |
| 4 | 1992 | 65 | |
| 5 | 2003 | 64 | |
| 6 | 2009 | 61 | |
| 7 | 2018 | 34 | |
| 8 | Cytochrome P450 3A4 activity in premenopausal and postmenopausal women, based on 6-beta-hydroxycortisol:cortisol ratios. | 1999 | 31 |
| 9 | 1997 | 29 | |
| 10 | 2014 | 29 | |
| 11 | 1990 | 29 | |
| 12 | 1998 | 25 | |
| 13 | 1991 | 24 | |
| 14 | 1990 | 23 | |
| 15 | 2015 | 19 | |
| 16 | Patterns of tocilizumab use, effectiveness and safety in patients with rheumatoid arthritis: core data results from a set of multinational observational studies. | 2018 | 11 |
| 17 | 1996 | 10 | |
| 18 | 2016 | 9 | |
| 19 | 1998 | 8 | |
| 20 | 2021 | 5 |
About William Reiss
William Reiss is a scholar working on Rheumatology, Genetics, Pathology and Forensic Medicine, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 37 papers that have together received 1.5k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (17 papers), Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (9 papers), Systemic Lupus Erythematosus Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Autoimmune and Inflammatory Disorders Research (3 papers) and Hormonal Regulation and Hypertension (3 papers). The work is most often cited by research in Infectious Diseases (641 citations), Neurology (463 citations), Rheumatology (199 citations), Critical Care and Intensive Care Medicine (66 citations) and Pharmacology (106 citations). William Reiss has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Karen S. Oles, Emma Kaplan‐Lewis, Jamie Freedman, Rachel Baden, Gerard J. Criner, Carlos Salama, Jian Han, Linda Yau, Jeffrey D. Neidhart and Lavannya M. Pandit. Their work appears in journals such as Annals of the Rheumatic Diseases, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Journal of Vascular Surgery, Rheumatology and Therapy and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.